📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Peer Medians

About

CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, national technology, and government healthcare consulting services. The Benefits and Insurance Services segment provides employee benefits consulting, payroll/human capital management, property and casualty insurance, and retirement and investment services. The National Practices segment offers information technology managed networking and hardware services. The company primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. CBIZ, Inc. was incorporated in 1987 and is headquartered in Independence, Ohio.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding CBZ

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Steve Cohen Point72 Asset Management	429.7K	$11.5M	0.01%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific ~ Volatile 4 quarters analysed

Q2 2025

Cautious

Management repeatedly used terms like 'uncertainty', 'headwinds', and 'challenging' to describe the macro environment, but also highlighted 'resiliency of our core and recurring essential business' and 'strong earnings'. They acknowledged that non-recurring project-based services are down low single digits and that pricing pressure is a $75M headwind, yet expressed confidence in achieving adjusted EBITDA and EPS guidance through proactive cost and revenue initiatives.

Q3 2025

Confident Specific

Management repeatedly used phrases like 'we couldn't be more pleased', 'strong validation', 'better than expected synergies', and 'line of sight' to express assurance in the Marcum integration and 2025 guidance, while providing specific metrics such as mid-single-digit pricing growth and a $50+ million synergy goal.

Q4 2025

Confident Specific

Management speaks with conviction about the completed Marcum integration, clear strategic priorities, and specific financial guidance (2%-5% revenue growth, $450M-$460M adjusted EBITDA). They acknowledge 2025 headwinds but highlight improving sentiment and concrete initiatives (e.g., 15% increase in producer count, offshoring expansion to 10%). Language like 'we believe', 'we are well positioned', and detailed outlook reinforce confidence.

Q1 2026 latest

Confident Specific

Management repeatedly stated Q1 results were 'in line with expectations' and reaffirmed full-year guidance, while quantifying headwinds (200bps drag from client exits and integration) and citing specific growth initiatives. They acknowledged B&I weakness from a producer departure but stressed confidence in the remaining year.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis appears slightly stronger after the call. Management provided concrete evidence that organic growth is improving sequentially and that integration headwinds are fading as planned. The AI and offshoring narrative is becoming more tangible with specific efficiency examples (20-40% productivity gains) and a clear rollout plan. However, the B&I segment's unexpected producer departure and continued client attrition in Financial Services (200bps headwind) introduce near-term uncertainty. The increased adjusted EPS guidance due to buybacks signals confidence in cash flow and undervaluation. Key next quarter watch items: B&I producer hiring progress, the pace of organic growth acceleration, and any further quantification of AI-driven margin benefits.

AI-generated concall tone analysis · Updated 2026-06-09 · Not investment advice

🎙 Management Tone Confident Specific ~ Volatile 4 quarters Full tone analysis in Intelligence →

📊 MIXED CBIZ Q1 2026: Revenue $849M, adjusted EBITDA $244M, organic growth 1%

Revenue & Profitability

Q1 2026 revenue increased 1.3% year-over-year to $849 million, with organic growth of 1%. Adjusted EBITDA was $244 million, up $3 million, and adjusted EPS was $2.50 versus $2.33 in Q1 2025. Free cash flow improved $64 million year-over-year. Full-year 2026 guidance: revenue $2.8–$2.9 billion, adjusted EBITDA $465–$475 million, adjusted EPS $4.00–$4.10.

Outlook

Management sees improving organic growth, with sequential improvement from Q4 2025 and expectations to exit 2026 at mid-single-digit growth. The advisory market remains favorable, with strong demand for risk advisory, credit risk, valuation, and private equity services. Capital markets activity is increasing. Management is confident in the full-year guidance, with growth expected to accelerate each quarter.

Growth Drivers

Key growth levers include: lateral hiring of high-producing managing directors in Financial Services, a 15% increase in net new producers in Benefits & Insurance, cross-selling through 12 industry verticals, AI-driven efficiency gains, and offshoring expansion (targeting 10% offshore hours in 2026, up from 6% in 2025). The company also launched a spring national brand campaign to drive engagement.

Balance Sheet & CapEx

Not discussed in this earnings call.

Margins

Adjusted EBITDA margin increased 10 basis points year-over-year in Q1. Management expects margin expansion driven by top-line growth and operating efficiencies from AI, automation, and offshoring. B&I margins were impacted by non-recurring revenue declines and planned marketing investments. Long-term, the company sees potential for significant margin improvement through these initiatives.

Key Risks

Risks flagged by management: integration-related client attrition reduced Financial Services organic growth by ~200 basis points in Q1, though expected to abate by H2. An isolated producer departure in B&I impacted first-quarter revenue. Residual integration productivity impacts shifted some tax revenue to the back half. Management has restrictive covenants in place and does not anticipate further departures.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q1 2026 Q1 2026 2026-04-29

First quarter 2026 results showed solid revenue, profitability, and free cash flow growth, with integration and AI initiatives driving efficiency and positioning for future gains. Guidance for revenue, EBITDA, and free cash flow was reaffirmed, and adjusted EPS was raised due to share repurchases.

Q4 2025 Q4 2025 2026-02-25

Revenue grew 52% in 2025, driven by a major acquisition and 2% organic growth, with strong margin expansion and free cash flow. 2026 guidance calls for 2%-5% revenue growth, continued margin gains, and robust cash generation, supported by AI, offshoring, and cross-selling initiatives.

Q3 2025 Q3 2025 2025-10-29

Q3 and year-to-date results showed strong revenue and margin growth, driven by the Marcum acquisition and operational efficiencies. Integration is ahead of schedule, with synergy targets raised and investments in technology and talent supporting future growth. Guidance for 2025 is maintained, with continued focus on margin expansion and capital allocation priorities.

Q2 2025 Q2 2025 2025-07-30

Second quarter and first half 2025 results showed strong growth in revenue and EBITDA, driven by the Marcum acquisition, despite ongoing economic headwinds impacting discretionary and market-sensitive services. Guidance remains at the low end of the range, with integration and cost initiatives supporting margins.

Q1 2025 Q1 2025 2025-04-24

First quarter results showed strong revenue and earnings growth, driven by the Marcum acquisition and robust recurring service lines, despite economic headwinds and softness in non-recurring services. Integration is on track, guidance for adjusted EBITDA and EPS is maintained, and leverage reduction remains a priority.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.